کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4330009 | 1614243 | 2008 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Neuroprotection in mice by NGP1-01 after transient focal brain ischemia
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
TTCCBFMCAO2,3,5-triphenyltetrazolium chloride - 2،3،5-trihenyltetrazolium chlorideNMDA receptor - NMDA گیرندهmiddle cerebral artery occlusion - انسداد شریان (سرخرگ) مغزی میانیTransient focal ischemia - ایسکمی کانونی گذراcerebral blood flow - جریان خون مغزیStroke - سکته مغزیvoltage-gated calcium channel - کانال کلسیم با ولتاژ
موضوعات مرتبط
علوم زیستی و بیوفناوری
علم عصب شناسی
علوم اعصاب (عمومی)
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
The effect of the polycyclic cage amine NGP1-01, a dual action antagonist at both L-type calcium channels and NMDA receptors, was measured after transient (1 h) focal cerebral ischemia in the mouse middle cerebral artery occlusion (MCAO) model. Mice were left untreated, or received NGP1-01 (20 mg/kg per dose intraperitoneally), memantine (20 mg/kg per dose intraperitoneally), or vehicle (DMSO) at 15 min, 24 h and 48 h after reperfusion. Sensorimotor function was tested daily for two weeks using the “corner test”, a proven paradigm for the assessment of functional integrity in rodents. NGP1-01 significantly reduced sensorimotor deficits over the 2-week period (p < 0.001, ANOVA). Although memantine was less effective than NGP1-01 (p < 0.05), it still significantly attenuated sensorimotor deficits in the animals. In a separate study, brain damage 3 days after stroke was determined histologically in mice receiving no treatment, DMSO, or NGP1-01 (dosages and dosage schedule same as above). Serial brain sections were stained for nonviable neurons with Fluoro-Jade B and the volume of damaged tissue was estimated. NGP1-01 treated mice had a significantly lower volume of brain damage (13 ± 7 mm3, p < 0.01) than both control groups (no treatment: 47 ± 4 mm3, DMSO: 50 ± 10 mm3). In conclusion, at weight-equivalent doses, NGP1-01 was at least as neuroprotective as the established NMDA receptor antagonist memantine. It may be a promising lead structure for the development of novel multiple-action drugs in treating ischemic stroke and other neurodegenerative diseases with an excitotoxic component.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Brain Research - Volume 1196, 27 February 2008, Pages 113-120
Journal: Brain Research - Volume 1196, 27 February 2008, Pages 113-120
نویسندگان
Jiukuan Hao, Alexander Mdzinarishvili, Thomas J. Abbruscato, Jochen Klein, Werner J. Geldenhuys, Cornelis J. Van der Schyf, Ulrich Bickel,